-
Recent Posts
Archives
Tags
access to medicines Africa AIDS Asia Asthma Society of Canada Bill C-51 burden of illness Canada China chronic conditions compulsory licencing Counterfeit drugs counterfeit medicines drug development drug pricing drug regulation economic development Europe Expert Working Group H1N1 health care IGWG IMPACT India Innovation intellectual property internet pharmacies least-developed countries malaria Millenium Development Goals natural health products neglected diseases Pan-American Health Organization patents patients patient safety Public health special interest groups Swine flu tuberculosis United Nations vaccine World Health Assembly World Health Organization World Intellectual Property Association
1356
Resources
Site Meter
Blog at WordPress.com. Theme: Digg 3 Column by WP Designer
Patients — the real stakeholders in global health
The response from Durhane Wong-Rieger of the Consumer Advocare Network to Robert Weissman’s article ’Big Pharma Digs In’ really hits home. If patients aren’t the key stakeholder in global health issues, then who is?
Comment by Durhane Wong Rieger:
Patients are the only stakeholders with a “life and death” stake in the WHO”s negotiations to meet needs of [...]
Filed under: Commentary on news & events | Tagged: Consumer Advocare Network, IGWG, intellectual property | Leave a Comment »